Drug General Information (ID: DDI3Q4WSKM)
  Drug Name Tiludronic acid Drug Info Ferrous gluconate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Bisphosphonates Iron Supplement
  Structure

 Mechanism of Tiludronic acid-Ferrous gluconate Interaction (Severity Level: Moderate)
     Complex formation Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Tiludronic acid Ferrous gluconate
      Mechanism Binds to polyvalent cations Polyvalent cations
      Key Mechanism Factor 1
Factor Name Chelation
Factor Description Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption.
      Mechanism Description
  • Decreased absorption of Ferrous gluconate due to formation of complexes caused by Tiludronic acid 

Recommended Action
      Management Antacids or other oral medications containing aluminum, calcium, magnesium and other polyvalent cations should be administered at least 2 hours before or 2 hours after the bisphosphonate dose.

References
1 Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
2 Product Information. Fosamax (alendronate). Merck &amp Co, Inc, West Point, PA.
3 Product Information. Skelid (tilundronate). Sanofi Winthrop Pharmaceuticals, New York, NY.